Antibodies that Modulate Immunity to Drug Resistant and Latent MTB Infections
US-2019352378-A1 · Nov 21, 2019 · US
US9512206B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9512206-B2 |
| Application number | US-201314378922-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 28, 2013 |
| Priority date | Feb 29, 2012 |
| Publication date | Dec 6, 2016 |
| Grant date | Dec 6, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides a monoclonal antibody that specifically binds to acid-fast bacillary lipoarabinomannan, particularly tubercle bacillary lipoarabinomannan, the antibody being set forth below: (A) a monoclonal antibody comprising a heavy chain variable region and a light chain variable region joined via a linker, the heavy chain variable region comprising heavy chains CDR1 to CDR3 shown in (a) to (c) below, and the light chain variable region comprising light chains CDR1 to CDR3 shown in (d) to (f) below: (a) heavy chain CDR1 consisting of the amino acid sequence set forth in SEQ ID NO: 1, (b) heavy chain CDR1 consisting of the amino acid sequence set forth in SEQ ID NO: 2, (c) heavy chain CDR1 consisting of the amino acid sequence set forth in SEQ ID NO: 3, (d) light chain CDR1 consisting of the amino acid sequence set forth in SEQ ID NO: 4, (e) light chain CDR1 consisting of the amino acid sequence set forth in SEQ ID NO: 5, and (f) light chain CDR1 consisting of the amino acid sequence set forth in SEQ ID NO: 6. The present invention further provides the use of the antibody.
Opening claim text (preview).
The invention claimed is: 1. A monoclonal antibody that is capable of binding to acid-fast bacillary lipoarabinomannan, said monoclonal antibody comprising a heavy chain variable region and a light chain variable region joined via a linker, the heavy chain variable region comprising heavy chains CDR1 to CDR3 shown in (a) to (c) below, and the light chains comprising CDR1 to CDR3 shown in (d) to (f) below: (a) a heavy chain CDR1 consisting of the amino acid sequence set forth in SEQ ID NO: 1, (b) a heavy chain CDR2 consisting of the amino acid sequence set forth in SEQ ID NO: 2, (c) a heavy chain CDR3 consisting of the amino acid sequence set forth in SEQ ID NO: 3, (d) a light chain CDR1 consisting of the amino acid sequence set forth in SEQ ID NO: 4, (e) a light chain CDR2 consisting of the amino acid sequence set forth in SEQ ID NO: 5, and (f) a light chain CDR3 consisting of the amino acid sequence set forth in SEQ ID NO: 6. 2. The monoclonal antibody according to claim 1 , wherein the monoclonal antibody consists of the amino acid sequence set forth in SEQ ID NO: 12. 3. The monoclonal antibody according to claim 1 or claim 2 , which is a monovalent or bivalent antibody. 4. A kit comprising the monoclonal antibody of claim 3 . 5. A kit comprising the monoclonal antibody of claim 1 or claim 2 . 6. A mycobacterium detection tool comprising a solution-absorbing piece formed from a material capable of transferring a test sample through capillary action, the solution-absorbing piece comprising: (1) a sample collection part for absorbing and collecting the test sample; (2) a labeled antibody part supporting a labeled monoclonal antibody that specifically reacts with acid-fast bacillary lipoarabinomannan; (3) a determination part including a test result display part (a) that has immobilized thereon an unlabeled monoclonal antibody that specifically reacts with acid-fast bacillary lipoarabinomannan; and (4) a solution absorption part for absorbing remaining solution of the test sample that has moved through the sample collection part, the labeled antibody part, and the determination part, wherein each of said labeled and said unlabeled monoclonal antibodies is an antibody of claim 1 or claim 2 . 7. The mycobacterium detection tool according to claim 6 , wherein the determination part (3) further comprises a control display part (b) having immobilized thereon an unlabeled antibody that reacts with the labeled monoclonal antibody, the control display part being disposed apart from the test result display part (a). 8. A mycobacterium detection tool comprising a solution-absorbing piece formed from a material capable of transferring a test sample through capillary action, the solution-absorbing piece comprising: (1) a sample collection part for absorbing and collecting the test sample; (2) a labeled antibody part supporting a labeled monoclonal antibody that specifically reacts with acid-fast bacillary lipoarabinomannan; (3) a determination part including a test result display part (a) that has immobilized thereon an unlabeled monoclonal antibody that specifically reacts with acid-fast bacillary lipoarabinomannan; and (4) a solution absorption part for absorbing remaining solution of the test sample that has moved through the sample collection part, the labeled antibody part, and the determination part, wherein each of said labeled and said unlabeled monoclonal antibodies is an antibody of claim 3 . 9. The mycobacterium detection tool according to claim 8 , wherein the determination part (3) further comprises a control display part (b) having immobilized thereon an unlabeled antibody that reacts with the labeled monoclonal antibody, the control display part being disposed apart from the test result display part (a).
Mycobacteriaceae (F) · CPC title
constructed by phage libraries · CPC title
Mycobacteria · CPC title
Single chain antibody (scFv) · CPC title
Valency · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.